Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Alkeon Capital Management
investor
United States
- New York
- 29/11/2022
- Series B
- $47,000,000
Alkeon Capital Management, LLC is a privately owned registered investment adviser. The firm invests in the global equity markets and employs long/short equity strategies to make its investments. Alkeon Capital Management has offices in New York, San Francisco and Hong Kong.
- Industry Investment Management
- Website https://www.alkeoncapital.com/
- LinkedIn https://www.linkedin.com/company/alkeon-capital-management/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)